“视网膜母细胞瘤生存差异”：发展中国家不断拓展的视野
"Retinoblastoma survival disparity": The expanding horizon in developing countries.
作者信息
Naseripour Masood
机构信息
Eye Research Center, Rassoul Akram Hospital, Tehran University of Medical Sciences, Niayesh Avenue, Sattar-khan Street, Tehran, Iran.
出版信息
Saudi J Ophthalmol. 2012 Apr;26(2):157-61. doi: 10.1016/j.sjopt.2012.02.003. Epub 2012 Feb 18.
Abstract
The patients' survival for the most common intraocular tumor in children, retinoblastoma, has a wide spectrum among the world countries. This study was conducted to provide an overview of the retinoblastoma survival disparity worldwide by discussing the trends of patients' survival, as well as recent advances in the management of retinoblastoma. The design of this study was literature review and commentary. Selected articles from PubMed (except one) including both developing and developed countries regarding the patients' survival in retinoblastoma were considered and reviewed critically. An analysis of 47 articles was performed. In conclusion, in spite of an obvious contrast of retinoblastoma survival disparity in the world, the expanding horizons in developing countries are promising and continuing on all fronts and results are hope-inspiring.
摘要
视网膜母细胞瘤是儿童最常见的眼内肿瘤，其患者生存率在世界各国差异很大。本研究旨在通过探讨患者生存趋势以及视网膜母细胞瘤治疗的最新进展，概述全球视网膜母细胞瘤生存差异情况。本研究采用文献综述和评论的设计方法。对从PubMed（除一篇外）选取的包括发展中国家和发达国家关于视网膜母细胞瘤患者生存情况的文章进行了认真考虑和审查。共对47篇文章进行了分析。总之，尽管全球视网膜母细胞瘤生存差异明显，但发展中国家不断拓展的视野在各方面都充满希望且成果鼓舞人心。
相似文献
1
"Retinoblastoma survival disparity": The expanding horizon in developing countries.“视网膜母细胞瘤生存差异”：发展中国家不断拓展的视野
Saudi J Ophthalmol. 2012 Apr;26(2):157-61. doi: 10.1016/j.sjopt.2012.02.003. Epub 2012 Feb 18.
2
Current therapy and recent advances in the management of retinoblastoma.视网膜母细胞瘤治疗现状与最新进展
Indian J Med Paediatr Oncol. 2012 Apr;33(2):80-8. doi: 10.4103/0971-5851.99731.
3
Global retinoblastoma survival and globe preservation: a systematic review and meta-analysis of associations with socioeconomic and health-care factors.全球视网膜母细胞瘤的生存率和眼球保留率：与社会经济和医疗保健因素关联的系统评价和荟萃分析。
Lancet Glob Health. 2022 Mar;10(3):e380-e389. doi: 10.1016/S2214-109X(21)00555-6. Epub 2022 Jan 27.
4
Orbital retinoblastoma: where do we go from here?
J Cancer Res Ther. 2011 Jan-Mar;7(1):11-4. doi: 10.4103/0973-1482.80429.
5
Disparities in Retinoblastoma Presentation, Treatment, and Outcomes in Developed and Less-Developed Countries.发达国家与欠发达国家视网膜母细胞瘤在临床表现、治疗及预后方面的差异
Semin Ophthalmol. 2016;31(4):310-6. doi: 10.3109/08820538.2016.1154177. Epub 2016 Apr 29.
6
Review: New horizons in retinoblastoma treatment: an updated review article.综述：视网膜母细胞瘤治疗的新视野：一篇更新的综述文章。
Mol Vis. 2022 Jul 11;28:130-146. eCollection 2022.
7
Frontiers in the management of retinoblastoma.视网膜母细胞瘤管理前沿
Am J Ophthalmol. 2009 Aug;148(2):192-8. doi: 10.1016/j.ajo.2009.04.004. Epub 2009 May 24.
8
Targeted chemotherapy in retinoblastoma: A step forward from patient survival to globe survival.视网膜母细胞瘤的靶向化疗：从患者生存到眼球保留的一大进步。
Eur J Ophthalmol. 2023 Jan;33(1):574-586. doi: 10.1177/11206721221093018. Epub 2022 Apr 13.
9
Publication Trends of Research on Retinoblastoma During 2001-2021: A 20-Year Bibliometric Analysis.2001 - 2021年视网膜母细胞瘤研究的出版趋势：一项20年的文献计量分析
Front Med (Lausanne). 2021 May 21;8:675703. doi: 10.3389/fmed.2021.675703. eCollection 2021.
10
Orbital retinoblastoma: Present status and future challenges - A review.眼眶视网膜母细胞瘤：现状与未来挑战——综述
Saudi J Ophthalmol. 2011 Apr;25(2):159-67. doi: 10.1016/j.sjopt.2010.10.010. Epub 2010 Oct 13.
引用本文的文献
1
Delving Into Retinoblastoma Genetics: Discovery of Novel Mutations and Their Clinical Impact: Retrospective Cohort Study.深入研究视网膜母细胞瘤遗传学：新突变的发现及其临床影响：一项回顾性队列研究。
Cancer Med. 2025 May;14(9):e70922. doi: 10.1002/cam4.70922.
2
Global, regional and national burden due to retinoblastoma in children aged younger than 10 years from 1990 to 2021.1990年至2021年10岁以下儿童视网膜母细胞瘤造成的全球、区域和国家负担。
BMC Med. 2024 Dec 31;22(1):604. doi: 10.1186/s12916-024-03827-9.
3
Retinoblastoma in Ethiopian Children: Imaging Findings and Staging.埃塞俄比亚儿童视网膜母细胞瘤：影像学表现与分期
Ethiop J Health Sci. 2024 Oct;34(Spec Iss 1):39-46. doi: 10.4314/ejhs.v34i1.7S.
4
Retinoblastoma programme outcome over a 10-year period in Lebanon: assessment of potential impact of the pandemic and economic crisis.黎巴嫩10年期视网膜母细胞瘤项目成果：评估大流行和经济危机的潜在影响
Eye (Lond). 2025 Mar;39(4):748-754. doi: 10.1038/s41433-024-03465-8. Epub 2024 Nov 19.
5
Overall survival and cause-specific mortality in a hospital-based cohort of retinoblastoma patients in São Paulo, Brazil.巴西圣保罗一家医院收治的视网膜母细胞瘤患者的总生存率和死因特异性死亡率。
Int J Cancer. 2025 Jan 1;156(1):69-78. doi: 10.1002/ijc.35127. Epub 2024 Aug 13.
6
Advancements in Retinoblastoma Treatment: Unraveling the Potential of Intravitreal Chemotherapy.视网膜母细胞瘤治疗进展：探索玻璃体内化疗的潜力
Cureus. 2024 Jan 26;16(1):e53012. doi: 10.7759/cureus.53012. eCollection 2024 Jan.
7
Treatment adherence in retinoblastoma: A retro-prospective cohort study in Ivory Coast and the Democratic Republic of Congo.视网膜母细胞瘤的治疗依从性：在科特迪瓦和刚果民主共和国进行的一项回顾性队列研究。
Cancer Rep (Hoboken). 2023 Dec 26;7(2):e1949. doi: 10.1002/cnr2.1949.
8
Metastatic retinoblastoma at presentation: Clinical presentation, treatment, and outcomes.初诊时的转移性视网膜母细胞瘤：临床表现、治疗及预后
Oman J Ophthalmol. 2023 Oct 18;16(3):524-528. doi: 10.4103/ojo.ojo_176_22. eCollection 2023 Sep-Dec.
9
Epidemiological and Clinical Presentation of Retinoblastoma among Nepalese Children in 2019.2019年尼泊尔儿童视网膜母细胞瘤的流行病学及临床表现
South Asian J Cancer. 2022 Nov 2;12(2):199-205. doi: 10.1055/s-0042-1757581. eCollection 2023 Apr.
10
Causes of death and survival analysis for patients with retinoblastoma in Jordan.约旦视网膜母细胞瘤患者的死因及生存分析
Front Med (Lausanne). 2023 Sep 4;10:1244308. doi: 10.3389/fmed.2023.1244308. eCollection 2023.
本文引用的文献
1
Report of Case of Double Glioma Treated with X-Ray.经X射线治疗的双胶质瘤病例报告。
Tex Med J (Austin). 1903 Feb;18(8):322-323.
2
Outcomes of integrating genetics in management of patients with retinoblastoma.将遗传学整合到视网膜母细胞瘤患者管理中的结果。
Arch Ophthalmol. 2011 Nov;129(11):1428-34. doi: 10.1001/archophthalmol.2011.292.
3
Targeting the p53 pathway in retinoblastoma with subconjunctival Nutlin-3a.眼内母细胞瘤中经结膜下施用 Nutlin-3a 靶向作用 p53 通路。
Cancer Res. 2011 Jun 15;71(12):4205-13. doi: 10.1158/0008-5472.CAN-11-0058. Epub 2011 Apr 22.
4
Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience.动脉内化疗治疗视网膜母细胞瘤：四年经验
Arch Ophthalmol. 2011 Jun;129(6):732-7. doi: 10.1001/archophthalmol.2011.5. Epub 2011 Feb 14.
5
Strategies to manage retinoblastoma in developing countries.发展中国家视网膜母细胞瘤的管理策略。
Pediatr Blood Cancer. 2011 Mar;56(3):341-8. doi: 10.1002/pbc.22843. Epub 2010 Nov 11.
6
Survival of retinoblastoma in less-developed countries impact of socioeconomic and health-related indicators.欠发达国家的视网膜母细胞瘤存活率：社会经济和健康相关指标的影响。
Br J Ophthalmol. 2010 Nov;94(11):1432-6. doi: 10.1136/bjo.2009.168062. Epub 2010 Aug 23.
7
Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy.视网膜母细胞瘤的治疗：眼球摘除术、静脉化疗和动脉内化疗的进展。
Curr Opin Ophthalmol. 2010 May;21(3):203-12. doi: 10.1097/ICU.0b013e328338676a.
8
Retinoblastoma: the challenges of management in Ibadan, Nigeria.视网膜母细胞瘤：尼日利亚伊巴丹的治疗挑战
J Pediatr Hematol Oncol. 2009 Aug;31(8):552-5. doi: 10.1097/MPH.0b013e31819c5275.
9
Development of retinoblastoma programs in Central America.中美洲视网膜母细胞瘤防治项目的开展情况。
Pediatr Blood Cancer. 2009 Jul;53(1):42-6. doi: 10.1002/pbc.21984.
10
The effect of therapy refusal against medical advice in retinoblastoma patients in a setting where treatment delays are common.在治疗延误情况常见的背景下，视网膜母细胞瘤患者拒绝遵循医嘱治疗的影响。
Ophthalmic Genet. 2009 Mar;30(1):31-6. doi: 10.1080/13816810802464320.
Zotero 插件